TSS
VTVT icon

Two Sigma Securities’s vTv Therapeutics VTVT Stock Holding History

Two Sigma Securities’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-761
Closed -$14.6K – 3646
2023
Q3 		$14.6K Buy
+761
New +$18.6K ﹤0.01% 2631
2023
Q1 		– Sell
-951
Closed -$25.2K – 3327
2022
Q4 		$25.2K Buy
951
+141
+17% +$4.66K ﹤0.01% 2247
2022
Q3 		$31K Buy
810
+365
+82% +$14.4K ﹤0.01% 2250
2022
Q2 		$13K Sell
445
-19
-4% -$487 ﹤0.01% 2020
2022
Q1 		$13K Sell
464
-614
-57% -$18.4K ﹤0.01% 2033
2021
Q4 		$43K Buy
1,078
+651
+152% +$35K ﹤0.01% 1299
2021
Q3 		$26K Buy
+427
New +$32.2K ﹤0.01% 1445
2019
Q3 		– Sell
-669
Closed -$38K – 2497
2019
Q2 		$38K Buy
+669
New +$40.2K ﹤0.01% 1907
2018
Q4 		– Sell
-425
Closed -$13K – 2890
2018
Q3 		$13K Buy
+425
New +$19.9K ﹤0.01% 2482

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Securities's VTVT Position: Q4 2023 in Review

Two Sigma Securities sold out of vTv Therapeutics (VTVT) in Q4 2023, closing a stake of 761 shares — an estimated $14.6K sold.

Two Sigma Securities first reported a position in VTVT in Q3 2018 and held it in 9 quarters. The position peaked at $43K in Q4 2021. 14 funds tracked by Wall St. Rank hold VTVT as of Q4 2023.

  • Two Sigma Securities reported no remaining vTv Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Securities sold 761 vTv Therapeutics shares in Q4 2023, an estimated $14.6K.
  • Two Sigma Securities first reported a position in vTv Therapeutics in Q3 2018 and held it in 9 quarters.
  • Two Sigma Securities's vTv Therapeutics position peaked at $43K in Q4 2021.
  • 14 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2023.

Based on Two Sigma Securities's 13F filing for Q4 2023, filed 14 Feb 2024.